Targeting RNA to treat neuromuscular disease.

Targeting RNA to treat neuromuscular disease.

The development of effective therapies for neuromuscular disorders such as Duchenne muscular dystrophy (DMD) is hampered by considerable challenges: skeletal muscle is the most abundant tissue in the body, and many neuromuscular disorders are multisystemic conditions. However, despite these barriers...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Muntoni, F, Wood, M
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2011

Eitemau Tebyg

RNA-targeted splice-correction therapy for neuromuscular disease.
gan: Wood, M, et al.
Cyhoeddwyd: (2010)

Syncoilin upregulation in muscle of patients with neuromuscular disease.
gan: Brown, S, et al.
Cyhoeddwyd: (2005)

Splicing therapy for neuromuscular disease.
gan: Douglas, A, et al.
Cyhoeddwyd: (2013)

Syncoilin expression in neuromuscular disorders
gan: Torelli, S, et al.
Cyhoeddwyd: (2001)

Syncoilin expression in neuromuscular disorders.
gan: Howman, E, et al.
Cyhoeddwyd: (2001)

Establishment and application of clinical biobanks in treating neuromuscular diseases
gan: Ya-wen ZHAO, et al.
Cyhoeddwyd: (2016-10-01)

Emerging oligonucleotide therapeutics for rare neuromuscular diseases
gan: Aoki, Y, et al.
Cyhoeddwyd: (2021)

Editorial: Genome and transcriptome editing to understand and treat neuromuscular diseases
gan: Rika Maruyama, et al.
Cyhoeddwyd: (2023-03-01)

RNA interference: from model organisms towards therapy for neural and neuromuscular disorders.
gan: Buckingham, S, et al.
Cyhoeddwyd: (2004)

Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseases
gan: Anja Holm, et al.
Cyhoeddwyd: (2022-12-01)

Systemic delivery of MicroRNA using recombinant adeno-associated virus serotype 9 to treat neuromuscular diseases in rodents
gan: Pourshafie, N, et al.
Cyhoeddwyd: (2018)

Emergency neuromuscular admissions are avoidable: a regional audit of unplanned hospital admissions of neuromuscular patients 2009-2011: final results and recommendations.
gan: Jaffer, F, et al.
Cyhoeddwyd: (2013)

RNA Targeting in Inherited Neuromuscular Disorders: Novel Therapeutic Strategies to Counteract Mis-Splicing
gan: Veronica Verdile, et al.
Cyhoeddwyd: (2021-10-01)

Subcutaneous immunoglobulin in treating inflammatory neuromuscular disorders
gan: Min-Suk Yoon, et al.
Cyhoeddwyd: (2015-07-01)

Multiple roles of integrin-α3 at the neuromuscular junction.
gan: Ross, J, et al.
Cyhoeddwyd: (2017)

Treating neuromuscular diseases: unveiling gene therapy breakthroughs and pioneering future applications
gan: Yu-Fu Wu, et al.
Cyhoeddwyd: (2025-02-01)

Abdominal compartment syndrome successfully treated with neuromuscular blockade
gan: Kris T Chiles, et al.
Cyhoeddwyd: (2011-01-01)

Diseases of the neuromuscular junction.
gan: McConville, J, et al.
Cyhoeddwyd: (2002)

Diagnosing Neuromuscular Diseases
gan: Alberto L. Dubrovsky
Cyhoeddwyd: (2018-08-01)

Neuromuscular Diseases and Bone
gan: Giovanni Iolascon, et al.
Cyhoeddwyd: (2019-11-01)

Neuromuscular diseases and anesthesia
gan: Antonijević Vesna, et al.
Cyhoeddwyd: (2018-01-01)

Role of RNA Binding Proteins with prion-like domains in muscle and neuromuscular diseases
gan: Gina Picchiarelli, et al.
Cyhoeddwyd: (2020-03-01)

Protein defects in neuromuscular diseases
gan: Vainzof M., et al.
Cyhoeddwyd: (2003-01-01)

Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches
gan: Mariot, V, et al.
Cyhoeddwyd: (2017)

Neuromuscular Blockade for Cardiac Arrest Patients Treated With Targeted Temperature Management: A Systematic Review and Meta-Analysis
gan: Tong Lin, et al.
Cyhoeddwyd: (2022-05-01)

Critical Illness Neuromuscular Disease
gan: J Gordon Millichap
Cyhoeddwyd: (1995-02-01)

Neuromuscular disease: 2023 update
gan: Marta Margeta
Cyhoeddwyd: (2023-02-01)

Modeling neuromuscular diseases in zebrafish
gan: Jaskaran Singh, et al.
Cyhoeddwyd: (2022-12-01)

Neuromuscular diseases: revisiting the "overtraining"
gan: Marco Orsini, et al.
Cyhoeddwyd: (2014-04-01)

Editorial: Imaging of Neuromuscular Diseases
gan: Jordi Diaz-Manera, et al.
Cyhoeddwyd: (2021-12-01)

Management of patients with neuromuscular disease /
gan: Bach, John R., 1950-
Cyhoeddwyd: (c200)

Development of a high-throughput tailored imaging method in zebrafish to understand and treat neuromuscular diseases
gan: Léa Lescouzères, et al.
Cyhoeddwyd: (2022-09-01)

Doenças neuromusculares Neuromuscular disorders
gan: Umbertina C. Reed
Cyhoeddwyd: (2002-08-01)

The Impact of Mitochondrial Deficiencies in Neuromuscular Diseases
gan: Judith Cantó-Santos, et al.
Cyhoeddwyd: (2020-10-01)

Predictors of overload in parents of children with neuromuscular diseases
gan: A. A. Rodríguez, et al.
Cyhoeddwyd: (2024-02-01)

Molecular targets for autoimmune and genetic disorders of neuromuscular transmission.
gan: Vincent, A, et al.
Cyhoeddwyd: (2000)

Neuromuscular disease. DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction.
gan: Arimura, S, et al.
Cyhoeddwyd: (2014)

RNA and glia at the Drosophila neuromuscular junction: importance for synaptic plasticity
gan: Gala, DS
Cyhoeddwyd: (2023)

Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies.
gan: Robb, SA, et al.
Cyhoeddwyd: (2011)

Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches
gan: Virginie Mariot, et al.
Cyhoeddwyd: (2017-11-01)